Search

Your search keyword '"Montalban A"' showing total 1,030 results
Start Over Author "Montalban A" Journal blood
1,030 results on '"Montalban A"'

1. Genetic and phenotypic attributes of splenic marginal zone lymphoma

Author

Bonfiglio, Ferdinando, Bruscaggin, Alessio, Guidetti, Francesca, Terzi di Bergamo, Lodovico, Faderl, Martin, Spina, Valeria, Condoluci, Adalgisa, Bonomini, Luisella, Forestieri, Gabriela, Koch, Ricardo, Piffaretti, Deborah, Pini, Katia, Pirosa, Maria Cristina, Cittone, Micol Giulia, Arribas, Alberto, Lucioni, Marco, Ghilardi, Guido, Wu, Wei, Arcaini, Luca, Baptista, Maria Joao, Bastidas, Gabriela, Bea, Silvia, Boldorini, Renzo, Broccoli, Alessandro, Buehler, Marco Matteo, Canzonieri, Vincenzo, Cascione, Luciano, Ceriani, Luca, Cogliatti, Sergio, Corradini, Paolo, Derenzini, Enrico, Devizzi, Liliana, Dietrich, Sascha, Elia, Angela Rita, Facchetti, Fabio, Gaidano, Gianluca, Garcia, Juan Fernando, Gerber, Bernhard, Ghia, Paolo, Gomes da Silva, Maria, Gritti, Giuseppe, Guidetti, Anna, Hitz, Felicitas, Inghirami, Giorgio, Ladetto, Marco, Lopez-Guillermo, Armando, Lucchini, Elisa, Maiorana, Antonino, Marasca, Roberto, Matutes, Estella, Meignin, Veronique, Merli, Michele, Moccia, Alden, Mollejo, Manuela, Montalban, Carlos, Novak, Urban, Oscier, David Graham, Passamonti, Francesco, Piazza, Francesco, Pizzolitto, Stefano, Rambaldi, Alessandro, Sabattini, Elena, Salles, Gilles, Santambrogio, Elisa, Scarfò, Lydia, Stathis, Anastasios, Stüssi, Georg, Geyer, Julia T., Tapia, Gustavo, Tarella, Corrado, Thieblemont, Catherine, Tousseyn, Thomas, Tucci, Alessandra, Vanini, Giorgio, Visco, Carlo, Vitolo, Umberto, Walewska, Renata, Zaja, Francesco, Zenz, Thorsten, Zinzani, Pier Luigi, Khiabanian, Hossein, Calcinotto, Arianna, Bertoni, Francesco, Bhagat, Govind, Campo, Elias, De Leval, Laurence, Dirnhofer, Stefan, Pileri, Stefano A., Piris, Miguel A., Traverse-Glehen, Alexandra, Tzankov, Alexander, Paulli, Marco, Ponzoni, Maurilio, Mazzucchelli, Luca, Cavalli, Franco, Zucca, Emanuele, and Rossi, Davide

Published
2022
Full Text
View/download PDF

2. Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN

Author

Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji, Estrov, Zeev, Cortes, Jorge, Ravandi, Farhad, Alvarado, Yesid, Komrokji, Rami, Sekeres, Mikkael A., Steensma, David P., DeZern, Amy, Roboz, Gail, Kantarjian, Hagop, and Garcia-Manero, Guillermo

Published
2017
Full Text
View/download PDF

3. Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)

Author

Jayastu Senapati, Emmanuel Huante Almanza, Tapan M. Kadia, Guillermo Montalban-Bravo, Stefan Faderl, Koji Sasaki, Nicholas Short, Naval Daver, Courtney D. DiNardo, Lucia Masarova, Alessandra Ferrajoli, Elias Jabbour, Gautam Borthakur, Hind Al Azzawi, Marina Konopleva, Guillermo Garcia-Manero, Michael Andreeff, Hagop Kantarjian, Farhad Ravandi, and Yesid Alvarado

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

4. Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML

Author

Naval Daver, Jayastu Senapati, Abhishek Maiti, Sanam Loghavi, Tapan M. Kadia, Courtney D. DiNardo, Naveen Pemmaraju, Elias Jabbour, Guillermo Montalban-Bravo, Guilin Tang, Koji Sasaki, Gautam Borthakur, Musa Yilmaz, Joie Alvarez, Sherry A. Pierce, Graciela M. Nogueras González, Jing Ning, Ghayas C. Issa, Michael Andreeff, Hussein A Abbas, Farhad Ravandi, Guillermo Garcia-Manero, and Hagop Kantarjian

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

5. Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with FLT3-Mutated Acute Myeloid Leukemia

Author

Nicholas Short, Courtney D. DiNardo, Naval Daver, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Ghayas C. Issa, Koji Sasaki, Philip A. Thompson, Jan A. Burger, Abhishek Maiti, Yesid Alvarado, Monica Kwari, Ricardo Delumpa, Jennifer Thankachan, Ejiroghene Mayor, Christopher Loiselle, Anna Milton, Glenda Banks, Tapan M. Kadia, Marina Konopleva, Hagop Kantarjian, and Farhad Ravandi

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

6. A Phase II Study of Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukemia: Durable Responses with Longer Term Follow-up

Author

Alexandre Bazinet, Hagop Kantarjian, Gautam Borthakur, Musa Yilmaz, Prithviraj Bose, Elias Jabbour, Yesid Alvarado, Kelly S. Chien, Naveen Pemmaraju, Koichi Takahashi, Nicholas Short, Naval Daver, Ghayas C. Issa, Nitin Jain, Debra Bull Linderman, Courtney D. DiNardo, Jan A. Burger, Alessandra Ferrajoli, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Koji Sasaki, Farhad Ravandi, and Tapan M. Kadia

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

7. A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure

Author

Faustine Ong, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Yesid Alvarado, Maro Ohanian, Marina Konopleva, Elias Jabbour, Nitin Jain, Gautam Borthakur, Courtney D. DiNardo, Naval Daver, Ghayas C. Issa, Koji Sasaki, Kelly S. Chien, Koichi Takahashi, Michael Andreeff, Muharrem Muftuoglu, Ricardo Delumpa, Ejiroghene Mayor, Christopher Loiselle, Lourdes Waller, Glenda Banks, Hagop Kantarjian, Jorge E. Cortes, and Nicholas Short

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

8. Cladribine with Low Dose Cytarabine for Unfit Patients: A Safe and Effective Approach with Low Early Mortality in a Population Ineligible for Clinical Trials

Author

Sai Prasad Desikan, Hagop Kantarjian, Elias Jabbour, Kelly S. Chien, Guillermo Montalban-Bravo, Yesid Alvarado, Gautam Borthakur, Ghayas C. Issa, Naval Daver, Naveen Pemmaraju, Musa Yilmaz, Danielle Hammond, Abhishek Maiti, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, and Tapan M. Kadia

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

9. Updated Phase IIb Results of Venetoclax with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia

Author

Sai Prasad Desikan, Marina Konopleva, Koichi Takahashi, Curtis A Lachowiez, Sanam Loghavi, Lian-Chun Xiao, Tapan M. Kadia, Naval Daver, Nicholas Short, Koji Sasaki, Gautam Borthakur, Ghayas C. Issa, Abhishek Maiti, Kelly S. Chien, Yesid Alvarado, Guillermo Montalban-Bravo, Lucia Masarova, Musa Yilmaz, Michael Andreeff, Elias Jabbour, Guillermo Garcia-Manero, Steven M. Kornblau, Farhad Ravandi, Hagop Kantarjian, and Courtney D. DiNardo

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

10. Incidence of Central Nervous System Toxicity and Cytokine Release Syndrome in Leukemia Patients Treated with Blinatumomab

Author

Elias Jabbour, Shilpa Paul, Dan E. Nichols, Faezeh Darbaniyan, Jenessa Lee, Koji Sasaki, Nicholas Short, Nitin Jain, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, Guillermo Montalban-Bravo, Gautham Borthakur, Rebecca Garris, Marina Konopleva, and Hagop Kantarjian

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

11. Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study

Author

Nicholas Short, Hagop Kantarjian, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia-Manero, Ghayas C. Issa, Walid Macaron, Fadi Haddad, Monica Kwari, Ricardo Delumpa, Ejiroghene Mayor, Wuliamatu Deen, Jennifer Thankachan, Christopher Loiselle, Juan Rivera, Anna Milton, Lourdes Waller, Glenda Banks, Rebecca Garris, Marina Konopleva, Farhad Ravandi, and Elias Jabbour

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

12. Uproleselan Added to Cladribine Plus Low Dose Cytarabine (LDAC) in Patients with Treated Secondary Acute Myeloid Leukemia (TS-AML)

Author

Emmanuel Almanza Huante, Hagop Kantarjian, Kelly S. Chien, Courtney D. DiNardo, Nicholas Short, Abhishek Maiti, Guillermo Montalban-Bravo, Naval Daver, Jitesh D. Kawedia, Kayleigh Bowie, Sherry A. Pierce, Farhad Ravandi, Marina Konopleva, Guillermo Garcia-Manero, and Tapan M. Kadia

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

14. RAS Pathway Mutations Are Associated with Progression after Hypomethylating Agent Therapy in Chronic Myelomonocytic Leukemia

Author

Guillermo Montalban-Bravo, Faezeh Darbaniyan, Kelly S. Chien, Danielle Hammond, Rashmi Kanagal-Shamanna, Tapan M. Kadia, Courtney D. DiNardo, Naval Daver, Farhad Ravandi, Elias Jabbour, Naveen Pemmaraju, Nicholas Short, Koichi Takahashi, Zeev E. Estrov, Sherry A. Pierce, Hagop Kantarjian, and Guillermo Garcia-Manero

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

16. The Frequency and Clinical Implications of ASXL2 Mutations in Myeloid Neoplasms

Author

Tareq Abuasab, Srdan Verstovsek, Gautam Borthakur, Rashmi Kanagal-Shamanna, Keyur Patel, Koichi Takahashi, Lucia Masarova, Prithviraj Bose, John Villarreal, Sherry A. Pierce, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Nicholas Short, Courtney D. DiNardo, Naval Daver, Farhad Ravandi, Hagop Kantarjian, and Musa Yilmaz

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

17. Clinical Characterization, Prognosis and Therapeutic Management of 181 Patients with Splenic Marginal Zone Lymphoma (SMZL): Real World Experience of the Geltamo Group

Author

Teresa Villalobos, Ana Muntañola Prat, Sonia González de Villambrosia, Maria J. Rodriguez-Salazar, Ana Isabel Jiminez Ubieto, Gabriela Bastidas-Mora, Raul Cordoba, Maria Stefania Infante, Maria Jesus Vidal, Francisco Javier Diaz-Galvez, Monica Baile, Mariana Bastos-Oreiro, Carlos Panizo, Juan-Manuel Sancho, Belen Navarro Matilla, Tomas García, Lourdes Escoda, Pau Abrisqueta, María José Terol, Raquel Del Campo, Armando López-Guillermo, Antonio Salar, and Carlos Montalban

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

18. Ponatinib and Blinatumomab for Patients with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Phase: A Subgroup Analysis from a Phase II Study

Author

Walid Macaron, Hagop Kantarjian, Nicholas Short, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia-Manero, Ghayas C. Issa, Fadi Haddad, Monica Kwari, Ricardo Delumpa, Ejiroghene Mayor, Wuliamatu Deen, Jennifer Thankachan, Christopher Loiselle, Juan Rivera, Anna Milton, Lourdes Waller, Glenda Banks, Rebecca Garris, Marina Konopleva, Farhad Ravandi, and Elias Jabbour

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

19. RAS Pathway Mutations Are Associated with Progression after Hypomethylating Agent Therapy in Chronic Myelomonocytic Leukemia

Author

Montalban-Bravo, Guillermo, primary, Darbaniyan, Faezeh, additional, Chien, Kelly S., additional, Hammond, Danielle, additional, Kanagal-Shamanna, Rashmi, additional, Kadia, Tapan M., additional, DiNardo, Courtney D., additional, Daver, Naval, additional, Ravandi, Farhad, additional, Jabbour, Elias, additional, Pemmaraju, Naveen, additional, Short, Nicholas, additional, Takahashi, Koichi, additional, Estrov, Zeev E., additional, Pierce, Sherry A., additional, Kantarjian, Hagop, additional, and Garcia-Manero, Guillermo, additional

Published
2022
Full Text
View/download PDF

20. Ponatinib and Blinatumomab for Patients with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Phase: A Subgroup Analysis from a Phase II Study

Author

Macaron, Walid, primary, Kantarjian, Hagop, additional, Short, Nicholas, additional, Jain, Nitin, additional, Huang, Xuelin, additional, Montalban-Bravo, Guillermo, additional, Kadia, Tapan M., additional, Daver, Naval, additional, Chien, Kelly S., additional, Alvarado, Yesid, additional, Garcia-Manero, Guillermo, additional, Issa, Ghayas C., additional, Haddad, Fadi, additional, Kwari, Monica, additional, Delumpa, Ricardo, additional, Mayor, Ejiroghene, additional, Deen, Wuliamatu, additional, Thankachan, Jennifer, additional, Loiselle, Christopher, additional, Rivera, Juan, additional, Milton, Anna, additional, Waller, Lourdes, additional, Banks, Glenda, additional, Garris, Rebecca, additional, Konopleva, Marina, additional, Ravandi, Farhad, additional, and Jabbour, Elias, additional

Published
2022
Full Text
View/download PDF

21. Homologous Recombination DNA Repair Deficiency Score Is Independent Prognostic Variable in Myelodysplastic Syndrome/ Acute Myeloid Leukemia with Complex Karyotype

Author

Nguyen, Ha, primary, Sasaki, Koji, additional, Ravandi, Farhad, additional, Luthra, Rajyalakshmi, additional, Patel, Keyur P., additional, Loghavi, Sanam, additional, Jelloul, Fatima Zahra, additional, Routbort, Mark, additional, Kalia, Awdesh, additional, Montalban-Bravo, Guillermo, additional, Chien, Kelly S., additional, Hu, Peter, additional, Yilmaz, Musa, additional, Bueso-Ramos, Carlos E., additional, Medeiros, L. Jeffrey, additional, Garcia-Manero, Guillermo, additional, and Kanagal-Shamanna, Rashmi, additional

Published
2022
Full Text
View/download PDF

22. A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure

Author

Ong, Faustine, primary, Garcia-Manero, Guillermo, additional, Montalban-Bravo, Guillermo, additional, Alvarado, Yesid, additional, Ohanian, Maro, additional, Konopleva, Marina, additional, Jabbour, Elias, additional, Jain, Nitin, additional, Borthakur, Gautam, additional, DiNardo, Courtney D., additional, Daver, Naval, additional, Issa, Ghayas C., additional, Sasaki, Koji, additional, Chien, Kelly S., additional, Takahashi, Koichi, additional, Andreeff, Michael, additional, Muftuoglu, Muharrem, additional, Delumpa, Ricardo, additional, Mayor, Ejiroghene, additional, Loiselle, Christopher, additional, Waller, Lourdes, additional, Banks, Glenda, additional, Kantarjian, Hagop, additional, Cortes, Jorge E., additional, and Short, Nicholas, additional

Published
2022
Full Text
View/download PDF

23. Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with FLT3-Mutated Acute Myeloid Leukemia

Author

Short, Nicholas, primary, DiNardo, Courtney D., additional, Daver, Naval, additional, Macaron, Walid, additional, Yilmaz, Musa, additional, Borthakur, Gautam, additional, Montalban-Bravo, Guillermo, additional, Garcia-Manero, Guillermo, additional, Issa, Ghayas C., additional, Sasaki, Koji, additional, Thompson, Philip A., additional, Burger, Jan A., additional, Maiti, Abhishek, additional, Alvarado, Yesid, additional, Kwari, Monica, additional, Delumpa, Ricardo, additional, Thankachan, Jennifer, additional, Mayor, Ejiroghene, additional, Loiselle, Christopher, additional, Milton, Anna, additional, Banks, Glenda, additional, Kadia, Tapan M., additional, Konopleva, Marina, additional, Kantarjian, Hagop, additional, and Ravandi, Farhad, additional

Published
2022
Full Text
View/download PDF

24. Clinical and Biological Effects of Canakinumab in Lower-Risk Myelodysplastic Syndromes (MDS): Results from a Phase 2 Clinical Trial

Author

Garcia-Manero, Guillermo, primary, Adema, Vera, additional, Urrutia, Samuel, additional, Ma, Feiyang, additional, Yang, Hui, additional, Ganan-Gomez, Irene, additional, Borthakur, Gautam, additional, Takahashi, Koichi, additional, Short, Nicholas, additional, Issa, Ghayas C., additional, Chien, Kelly S., additional, Montalban-Bravo, Guillermo, additional, Joseph, Joby, additional, and Colla, Simona, additional

Published
2022
Full Text
View/download PDF

25. Combined Structural Variant and Mutation Profiling for Comprehensive Characterization of Chromoanagenesis and TP53 Mutations in Myelodysplastic Syndromes with Complex Karyotype

Author

Yang, Hui, primary, Garcia-Manero, Guillermo, additional, Wei, Yue, additional, Sasaki, Koji, additional, Chien, Kelly S., additional, Tang, Zhenya, additional, Montalban-Bravo, Guillermo, additional, Kalia, Awdesh, additional, Luthra, Rajyalakshmi, additional, Medeiros, L. Jeffrey, additional, and Kanagal-Shamanna, Rashmi, additional

Published
2022
Full Text
View/download PDF

26. Uproleselan Added to Cladribine Plus Low Dose Cytarabine (LDAC) in Patients with Treated Secondary Acute Myeloid Leukemia (TS-AML)

Author

Almanza Huante, Emmanuel, primary, Kantarjian, Hagop, additional, Chien, Kelly S., additional, DiNardo, Courtney D., additional, Short, Nicholas, additional, Maiti, Abhishek, additional, Montalban-Bravo, Guillermo, additional, Daver, Naval, additional, Kawedia, Jitesh D., additional, Bowie, Kayleigh, additional, Pierce, Sherry A., additional, Ravandi, Farhad, additional, Konopleva, Marina, additional, Garcia-Manero, Guillermo, additional, and Kadia, Tapan M., additional

Published
2022
Full Text
View/download PDF

27. Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML

Author

Daver, Naval, primary, Senapati, Jayastu, additional, Maiti, Abhishek, additional, Loghavi, Sanam, additional, Kadia, Tapan M., additional, DiNardo, Courtney D., additional, Pemmaraju, Naveen, additional, Jabbour, Elias, additional, Montalban-Bravo, Guillermo, additional, Tang, Guilin, additional, Sasaki, Koji, additional, Borthakur, Gautam, additional, Yilmaz, Musa, additional, Alvarez, Joie, additional, Pierce, Sherry A., additional, Nogueras González, Graciela M., additional, Ning, Jing, additional, Issa, Ghayas C., additional, Andreeff, Michael, additional, Abbas, Hussein A, additional, Ravandi, Farhad, additional, Garcia-Manero, Guillermo, additional, and Kantarjian, Hagop, additional

Published
2022
Full Text
View/download PDF

28. Phase 2 Study of ASTX727 (cedazuridine/decitabine) Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Previously Untreated, Elderly Patients with AML Unfit for Chemotherapy

Author

Abuasab, Tareq, primary, Garcia-Manero, Guillermo, additional, Short, Nicholas, additional, Alvarado, Yesid, additional, Issa, Ghayas C., additional, Islam, Rubiul, additional, Maiti, Abhishek, additional, Yilmaz, Musa, additional, Jain, Nitin, additional, Masarova, Lucia, additional, Kornblau, Steven M., additional, Jabbour, Elias, additional, Pemmaraju, Naveen, additional, Montalban-Bravo, Guillermo, additional, Pierce, Sherry A., additional, DiNardo, Courtney D., additional, Kadia, Tapan M., additional, Daver, Naval, additional, Konopleva, Marina, additional, Kantarjian, Hagop, additional, and Ravandi, Farhad, additional

Published
2022
Full Text
View/download PDF

29. Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)

Author

Senapati, Jayastu, primary, Almanza, Emmanuel Huante, additional, Kadia, Tapan M., additional, Montalban-Bravo, Guillermo, additional, Faderl, Stefan, additional, Sasaki, Koji, additional, Short, Nicholas, additional, Daver, Naval, additional, DiNardo, Courtney D., additional, Masarova, Lucia, additional, Ferrajoli, Alessandra, additional, Jabbour, Elias, additional, Borthakur, Gautam, additional, Al Azzawi, Hind, additional, Konopleva, Marina, additional, Garcia-Manero, Guillermo, additional, Andreeff, Michael, additional, Kantarjian, Hagop, additional, Ravandi, Farhad, additional, and Alvarado, Yesid, additional

Published
2022
Full Text
View/download PDF

30. Myelodysplastic Syndromes without Detectable Mutations: Analysis of Clinical Presentation and Outcome

Author

Bataller, Alex, primary, Kanagal-Shamanna, Rashmi, additional, Chien, Kelly S., additional, Montalban-Bravo, Guillermo, additional, Kadia, Tapan M., additional, Ravandi, Farhad, additional, DiNardo, Courtney D., additional, Daver, Naval, additional, Short, Nicholas, additional, Borthakur, Gautam, additional, Jabbour, Elias, additional, Hammond, Danielle, additional, Masarova, Lucia, additional, Ganan-Gomez, Irene, additional, Adema, Vera, additional, Kantarjian, Hagop, additional, Garcia-Manero, Guillermo, additional, and Sasaki, Koji, additional

Published
2022
Full Text
View/download PDF

31. Venetoclax Added to Cladribine (CLAD) + Low Dose AraC (LDAC) Alternating with Azacitidine (AZA) Is Highly Active As Frontline Therapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia in a Phase 2 Study

Author

Reville, Patrick K, primary, Kantarjian, Hagop, additional, Borthakur, Gautam, additional, Pemmaraju, Naveen, additional, Daver, Naval, additional, DiNardo, Courtney D., additional, Sasaki, Koji, additional, Short, Nicholas, additional, Issa, Ghayas C., additional, Ohanian, Maro, additional, Jabbour, Elias, additional, Montalban-Bravo, Guillermo, additional, Maiti, Abhishek, additional, Jain, Nitin, additional, Ferrajoli, Alessandra, additional, Bhalla, Kapil N., additional, Takahashi, Koichi, additional, Rausch, Caitlin R., additional, Hammond, Danielle, additional, Malla, Rashmi, additional, Quagliato, Kelly, additional, Brandt, Mark, additional, Popat, Uday R, additional, Konopleva, Marina, additional, Garcia-Manero, Guillermo, additional, Ravandi, Farhad, additional, and Kadia, Tapan M., additional

Published
2022
Full Text
View/download PDF

32. Incidence of Central Nervous System Toxicity and Cytokine Release Syndrome in Leukemia Patients Treated with Blinatumomab

Author

Jabbour, Elias, primary, Paul, Shilpa, additional, Nichols, Dan E., additional, Darbaniyan, Faezeh, additional, Lee, Jenessa, additional, Sasaki, Koji, additional, Short, Nicholas, additional, Jain, Nitin, additional, Ravandi, Farhad, additional, Garcia-Manero, Guillermo, additional, Kadia, Tapan M., additional, Montalban-Bravo, Guillermo, additional, Borthakur, Gautham, additional, Garris, Rebecca, additional, Konopleva, Marina, additional, and Kantarjian, Hagop, additional

Published
2022
Full Text
View/download PDF

33. Del5q with One Additional Cytogenetic Abnormality Other Than Del20q Identifies a Higher Risk Population of MDS Patients

Author

Briski, Robert E., primary, Chien, Kelly S., additional, Montalban-Bravo, Guillermo, additional, Kadia, Tapan M., additional, Jabbour, Elias, additional, Pemmaraju, Naveen, additional, Sasaki, Koji, additional, Hammond, Danielle, additional, Short, Nicholas, additional, Ravandi, Farhad, additional, Alvarado, Yesid, additional, Pierce, Sherry A., additional, Garcia-Manero, Guillermo, additional, and Kantarjian, Hagop, additional

Published
2022
Full Text
View/download PDF

34. A Phase II Study of Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukemia: Durable Responses with Longer Term Follow-up

Author

Bazinet, Alexandre, primary, Kantarjian, Hagop, additional, Borthakur, Gautam, additional, Yilmaz, Musa, additional, Bose, Prithviraj, additional, Jabbour, Elias, additional, Alvarado, Yesid, additional, Chien, Kelly S., additional, Pemmaraju, Naveen, additional, Takahashi, Koichi, additional, Short, Nicholas, additional, Daver, Naval, additional, Issa, Ghayas C., additional, Jain, Nitin, additional, Bull Linderman, Debra, additional, DiNardo, Courtney D., additional, Burger, Jan A., additional, Ferrajoli, Alessandra, additional, Montalban-Bravo, Guillermo, additional, Garcia-Manero, Guillermo, additional, Sasaki, Koji, additional, Ravandi, Farhad, additional, and Kadia, Tapan M., additional

Published
2022
Full Text
View/download PDF

35. Clinical Characterization, Prognosis and Therapeutic Management of 181 Patients with Splenic Marginal Zone Lymphoma (SMZL): Real World Experience of the Geltamo Group

Author

Villalobos, Teresa, primary, Muntañola Prat, Ana, additional, González de Villambrosia, Sonia, additional, Rodriguez-Salazar, Maria J., additional, Jiminez Ubieto, Ana Isabel, additional, Bastidas-Mora, Gabriela, additional, Cordoba, Raul, additional, Infante, Maria Stefania, additional, Vidal, Maria Jesus, additional, Diaz-Galvez, Francisco Javier, additional, Baile, Monica, additional, Bastos-Oreiro, Mariana, additional, Panizo, Carlos, additional, Sancho, Juan-Manuel, additional, Navarro Matilla, Belen, additional, García, Tomas, additional, Escoda, Lourdes, additional, Abrisqueta, Pau, additional, Terol, María José, additional, Del Campo, Raquel, additional, López-Guillermo, Armando, additional, Salar, Antonio, additional, and Montalban, Carlos, additional

Published
2022
Full Text
View/download PDF

36. Updated Phase IIb Results of Venetoclax with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia

Author

Desikan, Sai Prasad, primary, Konopleva, Marina, additional, Takahashi, Koichi, additional, Lachowiez, Curtis A, additional, Loghavi, Sanam, additional, Xiao, Lian-Chun, additional, Kadia, Tapan M., additional, Daver, Naval, additional, Short, Nicholas, additional, Sasaki, Koji, additional, Borthakur, Gautam, additional, Issa, Ghayas C., additional, Maiti, Abhishek, additional, Chien, Kelly S., additional, Alvarado, Yesid, additional, Montalban-Bravo, Guillermo, additional, Masarova, Lucia, additional, Yilmaz, Musa, additional, Andreeff, Michael, additional, Jabbour, Elias, additional, Garcia-Manero, Guillermo, additional, Kornblau, Steven M., additional, Ravandi, Farhad, additional, Kantarjian, Hagop, additional, and DiNardo, Courtney D., additional

Published
2022
Full Text
View/download PDF

37. A Phase I/II Study of Seclidemstat, an LSD1 Inhibitor, and Azacitidine for Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Author

Montalban-Bravo, Guillermo, primary, DiNardo, Courtney D., additional, Short, Nicholas, additional, Kadia, Tapan M., additional, Ravandi, Farhad, additional, Chien, Kelly S., additional, Joseph, Joby, additional, Waukau, Jane, additional, Pierce, Sherry A., additional, Kantarjian, Hagop, additional, and Garcia-Manero, Guillermo, additional

Published
2022
Full Text
View/download PDF

39. Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study

Author

Short, Nicholas, primary, Kantarjian, Hagop, additional, Jain, Nitin, additional, Huang, Xuelin, additional, Montalban-Bravo, Guillermo, additional, Kadia, Tapan M., additional, Daver, Naval, additional, Chien, Kelly S., additional, Alvarado, Yesid, additional, Garcia-Manero, Guillermo, additional, Issa, Ghayas C., additional, Macaron, Walid, additional, Haddad, Fadi, additional, Kwari, Monica, additional, Delumpa, Ricardo, additional, Mayor, Ejiroghene, additional, Deen, Wuliamatu, additional, Thankachan, Jennifer, additional, Loiselle, Christopher, additional, Rivera, Juan, additional, Milton, Anna, additional, Waller, Lourdes, additional, Banks, Glenda, additional, Garris, Rebecca, additional, Konopleva, Marina, additional, Ravandi, Farhad, additional, and Jabbour, Elias, additional

Published
2022
Full Text
View/download PDF

40. Impact of Spliceosome Mutations on the Prognosis of Myelodysplastic Syndrome (MDS)

Author

Urrutia, Samuel, primary, Sasaki, Koji, additional, Kanagal-Shamanna, Rashmi, additional, Bataller, Alex, additional, Montalban-Bravo, Guillermo, additional, Ganan-Gomez, Irene, additional, Wei, Yue, additional, Yang, Hui, additional, Chien, Kelly S., additional, Hammond, Danielle, additional, Bueso-Ramos, Carlos E., additional, Pierce, Sherry A., additional, Kantarjian, Hagop, additional, and Garcia-Manero, Guillermo, additional

Published
2022
Full Text
View/download PDF

41. Cladribine with Low Dose Cytarabine for Unfit Patients: A Safe and Effective Approach with Low Early Mortality in a Population Ineligible for Clinical Trials

Author

Desikan, Sai Prasad, primary, Kantarjian, Hagop, additional, Jabbour, Elias, additional, Chien, Kelly S., additional, Montalban-Bravo, Guillermo, additional, Alvarado, Yesid, additional, Borthakur, Gautam, additional, Issa, Ghayas C., additional, Daver, Naval, additional, Pemmaraju, Naveen, additional, Yilmaz, Musa, additional, Hammond, Danielle, additional, Maiti, Abhishek, additional, DiNardo, Courtney D., additional, Ravandi, Farhad, additional, Garcia-Manero, Guillermo, additional, and Kadia, Tapan M., additional

Published
2022
Full Text
View/download PDF

42. The Frequency and Clinical Implications of ASXL2 Mutations in Myeloid Neoplasms

Author

Abuasab, Tareq, primary, Verstovsek, Srdan, additional, Borthakur, Gautam, additional, Kanagal-Shamanna, Rashmi, additional, Patel, Keyur, additional, Takahashi, Koichi, additional, Masarova, Lucia, additional, Bose, Prithviraj, additional, Villarreal, John, additional, Pierce, Sherry A., additional, Montalban-Bravo, Guillermo, additional, Garcia-Manero, Guillermo, additional, Short, Nicholas, additional, DiNardo, Courtney D., additional, Daver, Naval, additional, Ravandi, Farhad, additional, Kantarjian, Hagop, additional, and Yilmaz, Musa, additional

Published
2022
Full Text
View/download PDF

43. Genomic Evolution of Patients with Myelodysplastic Syndrome after Hypomethylating Agent Failure

Author

Chien, Kelly S., primary, Kim, Kunhwa, additional, Li, Ziyi, additional, Kanagal-Shamanna, Rashmi, additional, Ong, Faustine, additional, Montalban-Bravo, Guillermo, additional, Kadia, Tapan M., additional, Jabbour, Elias, additional, Pemmaraju, Naveen, additional, Hammond, Danielle, additional, Short, Nicholas, additional, Ravandi, Farhad, additional, Alvarado, Yesid, additional, Pierce, Sherry A., additional, Dong, Xiao Qin, additional, Yang, Hui, additional, Wei, Yue, additional, Ganan-Gomez, Irene, additional, Colla, Simona, additional, Kantarjian, Hagop, additional, and Garcia-Manero, Guillermo, additional

Published
2022
Full Text
View/download PDF

44. GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?

Author

Mateos, María-Victoria, Oriol, Albert, Martínez-López, Joaquín, Teruel, Ana-Isabel, López de la Guía, Ana, López, Javier, Bengoechea, Enrique, Pérez, Montserrat, Martínez, Rafael, Palomera, Luis, de Arriba, Felipe, González, Yolanda, Hernández, José Mariano, Granell, Miquel, Bello, José-Luis, Bargay, Joan, Peñalver, Francisco-Javier, Martín-Mateos, María-Luisa, Paiva, Bruno, Montalbán, María-Angeles, Bladé, Joan, Lahuerta, Juan-Jose, and San-Miguel, Jesús F.

Published
2014
Full Text
View/download PDF

45. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Author

Martinez-Lopez, Joaquin, Lahuerta, Juan J., Pepin, François, González, Marcos, Barrio, Santiago, Ayala, Rosa, Puig, Noemí, Montalban, María A., Paiva, Bruno, Weng, Li, Jiménez, Cristina, Sopena, María, Moorhead, Martin, Cedena, Teresa, Rapado, Immaculada, Mateos, María Victoria, Rosiñol, Laura, Oriol, Albert, Blanchard, María J., Martínez, Rafael, Bladé, Joan, San Miguel, Jesús, Faham, Malek, and García-Sanz, Ramón

Published
2014
Full Text
View/download PDF

46. Comprehensive Geriatric Assessment Is a Useful Tool for Predicting the Outcome of Elderly Patients with Hematologic Malignancies in Real Life

Author

González-gascón-y-Marín, Isabel, Martínez-Flores, Sara, Landete, Elena, Baeza-Monedero, Elena, Foncillas, María Ángeles, Fernández-Montalbán, Paula, Muñoz-Novas, Carolina Cecilia, Infante, Maria Stefania, Marín-Mori, Karen, Churruca Sarasqueta, Juan, Sánchez-Paz, Laura, Ramos-de-Ascanio, Victoria, Brañas, Fátima, and Hernández-Rivas, José Ángel

Published
2022
Full Text
View/download PDF

47. Predictive Value of Platelet Sequestration Studies in Splenectomy Response

Author

Mendoza, Ana, Butta, Nora V., Monzón Manzano, Elena, Acuña, Paula, G Arias-Salgado, Elena, Rivas Pollmar, María Isabel, Martín Salces, Mónica, Gutierrez, Mar, Garcia Perez, Eduardo, Ramirez Lopez, Andres, Gómez Serrano, Leticia, Martin de Bustamante Gonzalez-Iglesias, Jose Manuel, Martínez de Miguel, Barbara, Martínez Montalbán, Elena, Dobra, Elena, Hermans, Cédric, Jiménez-Yuste, Víctor, and Alvarez Román, María Teresa

Published
2022
Full Text
View/download PDF

48. Homologous Recombination DNA Repair Deficiency Score Is Independent Prognostic Variable in Myelodysplastic Syndrome/ Acute Myeloid Leukemia with Complex Karyotype

Author

Ha Nguyen, Koji Sasaki, Farhad Ravandi, Rajyalakshmi Luthra, Keyur P. Patel, Sanam Loghavi, Fatima Zahra Jelloul, Mark Routbort, Awdesh Kalia, Guillermo Montalban-Bravo, Kelly S. Chien, Peter Hu, Musa Yilmaz, Carlos E. Bueso-Ramos, L. Jeffrey Medeiros, Guillermo Garcia-Manero, and Rashmi Kanagal-Shamanna

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results